Skip to main content
Premium Trial:

Request an Annual Quote

DoubleTwist Proposes Offering Price

NEW YORK, Oct 16 - DoubleTwist, next in the bioinformatics IPO queue, is seeking to raise at least $65 million through an offer of 5 million shares in a proposed price range of $13 to $15 a share, according to an S-1 amendment the company filed Friday.

The company, which originally announced its plan to go public on Sept. 1, has applied to be listed on the Nasdaq under the symbol DBLT. A DoubleTwist spokeswoman said that the date the company's stock would begin trading has not yet been determined.

The underwriters, led by Lehman Brothers, have the option to purchase an additional 750,000 shares to cover overallotments.

In its recent filing the company said it plans to use the proceeds from the offering for product development, sales and maketing, general corporate purposes, and possible acquisitions.

The company’s product line includes DoubleTwist.com, an online research portal; Prophecy, a proprietary annotated human genome database; GeneForest, an annotated human gene index; and its Gene Clustering and Alignment Tools software.

The Oakland, Calif.-based company sells subscriptions to its products through its website.

 

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.